A material adverse effect clause is a contract provision in a merger agreement or financing commitment that lets a buyer or lender refuse to close when the target company’s value has fundamentally deteriorated between signing and closing. In practice, these clauses almost never get successfully invoked. Courts set the proof bar extraordinarily high, and the buyer carries the burden. But the wording of the clause still drives some of the hardest negotiating in any significant deal, because when it does matter, hundreds of millions of dollars can turn on a single carve-out.
What the Clause Actually Does
An MAE definition has two moving parts. There has to be an event, meaning some occurrence, development, or change affecting the target company, and there has to be an effect, meaning a consequence serious enough to hit the company’s financial condition, operations, or earnings. Both halves have to be present. A dramatic event that doesn’t move the bottom line won’t trigger the clause, and a financial dip without a qualifying cause may not either.
The agreement typically builds the definition in through two separate mechanisms. First, the seller represents that no material adverse effect has occurred since a specific date, usually the most recent audited balance sheet. If that representation is false at closing, the buyer has grounds to walk. Second, the agreement includes a closing condition requiring that no MAE has occurred between signing and closing. The dual structure covers both pre-existing problems that surface later and new deterioration that develops in the interim.
What Gets Carved Out of the Definition
A raw MAE definition would be far too broad. If any negative change qualified, a buyer could walk every time the stock market dipped or Congress passed new legislation. Sellers negotiate carve-outs that remove broad external risks from the definition entirely. The standard list covers general economic downturns, interest rate fluctuations, stock market volatility, changes in law or accounting standards, geopolitical events like war or terrorism, and effects caused by the announcement of the deal itself. Pandemic and epidemic events are now standard additions after 2020.
These carve-outs effectively force the buyer to absorb macro-level risks that hit the whole market or industry. There is one important counter-mechanism: the disproportionate impact exception. Even when a carved-out event like a general downturn is the cause, the buyer can still invoke the MAE clause if the target suffers significantly worse damage than comparable businesses in its industry. If the whole pharmaceutical sector drops 15% but the target drops 60%, the carve-out does not shield the seller. How “disproportionate” gets measured is one of the more contentious drafting exercises in any deal.
Cybersecurity is still an open question. Some agreements place cyber incidents inside the carve-out list, so the buyer absorbs that risk. Others leave cyber events inside the MAE definition, preserving the buyer’s exit if a major breach hits before closing. The issue has not been directly litigated in a reported MAE case, so buyers with real data-security concerns need to negotiate rather than rely on how a court might read a standard clause.
What a Buyer Has to Prove
Courts look at two things: how severe the decline is, and how long it is expected to last. The bar is high on both.
Durational Significance
The most important judicial requirement is that the adverse change be durationally significant. A bad quarter will not do it. Two bad quarters will probably not do it. Courts expect the decline to be consequential to the company’s long-term earnings power over a commercially reasonable period, which usually means measuring the impact in years, not months. A seasonal slump or a temporary earnings miss is exactly the kind of short-term fluctuation the clause is not designed to capture.
Magnitude
There is no bright-line percentage that automatically counts as an MAE. But courts have repeatedly referenced a 40% decline in profits as a rough threshold where findings of materiality become plausible, drawing on an influential M&A treatise that surveyed decades of outcomes. One earlier Delaware opinion suggested that a 50% earnings decline over two consecutive quarters would likely qualify. These are signals, not rules, but they tell you the kind of magnitude courts expect to see.
The Akorn Benchmark
For decades, no buyer had ever won an MAE case in Delaware. That changed in 2018 with Akorn, Inc. v. Fresenius Kabi AG, and the facts show how bad things need to get. Between signing and the attempted closing, Akorn’s full-year EBITDA dropped 86% year over year. Revenue fell 25%. Operating income and earnings per share swung from positive numbers to losses. On top of the financial collapse, Akorn had serious regulatory compliance failures the court found were company-specific rather than industry-wide. The decline had already persisted for a full year with no sign of recovery, and the underlying causes were structural, not cyclical. Using the merger agreement’s implied equity value of $4.3 billion, the court estimated the valuation hit at roughly $900 million, about 21% of total enterprise value. That is the kind of devastation an MAE requires.
Why Buyers Usually Lose
The buyer carries the burden of proving an MAE, and courts have consistently described that burden as heavy. The reasoning is straightforward: two sophisticated parties signed a binding agreement, and one of them now wants out. The strong default is that signed contracts should be honored.
In the IBP case, the Delaware Court of Chancery rejected Tyson Foods’ MAE claim even though IBP had experienced a notable earnings decline. The shortfall was seasonal, the industry was cyclical, and the dip was foreseeable. The court ordered Tyson to close anyway, framing the buyer’s position as buyer’s remorse rather than a legitimate MAE. In Channel Medsystems v. Boston Scientific, the same court again found that the buyer failed to establish an MAE and granted specific performance, forcing the closing. The pattern across these cases is consistent. Courts scrutinize whether the buyer is genuinely facing a fundamentally different deal or simply looking for an exit from a commitment it regrets.
The Ordinary Course Covenant: Often the Easier Path
Experienced deal lawyers know the MAE clause is often the hardest route to terminating an acquisition. A more practical alternative is the ordinary course of business covenant, a separate contractual promise that the target will keep running normally between signing and closing.
The threshold for breaching this covenant is meaningfully lower. The obligation is typically absolute: the seller either operated consistently with past practice or it did not. There is no efforts qualifier and no need to show the kind of catastrophic, durationally significant decline an MAE requires. Small deviations are excused as immaterial, but significant operational departures from historical patterns will breach the covenant regardless of whether the seller acted reasonably or in good faith.
AB Stable VIII LLC v. MAPS Hotels made the point sharply. The hotel seller restructured operations during the pandemic, closing properties, furloughing staff, and halting capital projects. The Delaware Supreme Court held that these operational changes breached the ordinary course covenant even though the pandemic itself fell within a specific MAE carve-out. The two provisions operate independently and serve different purposes. The MAE clause allocates valuation risk. The ordinary course covenant protects the buyer against operational changes during the interim period. A pandemic carve-out in one does nothing to excuse behavior under the other. Sellers who want protection against this result need to explicitly link the ordinary course covenant to the MAE carve-outs when the deal is negotiated.
What Happens When a Buyer Invokes the Clause
Termination and the Reverse Termination Fee
The most direct consequence of a proven MAE is the buyer’s right to terminate the merger agreement entirely. If the MAE is validly established, the buyer walks without paying a reverse termination fee. In private equity deals with debt financing, reverse termination fees typically run around 5% to 6% of enterprise value, so the stakes of whether an MAE actually occurred can reach hundreds of millions of dollars on the fee question alone.
Renegotiation
Most MAE disputes do not end in termination. The more common outcome is aggressive renegotiation. A buyer with credible evidence of material deterioration uses the threat of walking to push for a lower purchase price or restructured terms. Sellers often prefer a discounted closing to the alternative: a collapsed deal, public embarrassment, potential shareholder litigation, and the difficulty of finding another buyer after a failed process. The dynamic consistently favors the buyer once the MAE argument has teeth.
Specific Performance Can Force the Buyer to Close
Buyers sometimes assume that invoking an MAE means they can simply refuse to close. That assumption is dangerous. Modern merger agreements routinely include specific performance clauses that let the seller go to court and force the buyer to complete the deal. If the MAE claim fails, the court can order closing at the original price.
That is what happened in IBP, where the court ordered Tyson Foods to close, reasoning that the damages from a lost merger were too difficult to quantify in money alone. Channel Medsystems reached the same result. Delaware courts have signaled increasing willingness to enforce these provisions when the contract clearly reflects specific performance as the intended remedy. For buyers, an unsuccessful MAE claim does not just fail to terminate the deal. It can actively compel closing on the original terms, after months of expensive litigation the buyer now has to absorb on top of the purchase price.
The Financing Gap in Leveraged Deals
In leveraged acquisitions, the buyer finances the purchase with committed debt from a group of lenders. That debt financing has its own MAE condition in the commitment letter, and the definition in the commitment letter may not match the one in the merger agreement.
If the commitment letter’s MAE definition is broader, the buyer can land in a nightmare scenario. The lender refuses to fund because a change constitutes an MAE under the commitment letter, but the seller can still force closing because the same change does not constitute an MAE under the merger agreement. The buyer is contractually obligated to close a deal it cannot finance. The options at that point are both bad: condition the acquisition on financing availability (which sellers generally refuse), or absorb the risk that the lender’s MAE triggers before the seller’s does.
Lenders typically insist on protections called Xerox provisions, named after a 2009 Xerox acquisition agreement. These establish that the buyer’s reverse termination fee is the seller’s only remedy, prevent the seller from suing the lenders directly, require any financing-related litigation to be heard in New York courts, and waive jury trials for those disputes. Sophisticated buyers try to align the MAE definitions across both documents, but lenders often push back, wanting to preserve their own, broader exit rights.